HomeSpeakersAgendaContact

THT Biomaterials GmbH

Company (SME)

tht-biomaterials.com/Vienna, Austria
1 profile visit

About

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up and de-risk research and medical translations as it makes its results more realistic by replacing animal components with Sustainable, Standardized and Human components.

Circular Economy

Solutions to use less material or energySolutions to recover and recycle resources

Defense and security

Defense and security

Services

Project Development

Life Science, Healthcare & Cosmetics

Bio Technology (Biotech)HealthcarePharmaOther – Life Sciences

Waste Cycle

Waste managementWaste selection and recycling

Representatives

Johannes Hackethal

CEO, founder

THT Biomaterials GmbH

Marketplace (1)

  • Product

    Animal material free cell culture from medical waste

    THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices by replacing animal components with human components.

    • Life Science, Healthcare & Cosmetics
    Author

    Johannes Hackethal

    CEO, founder at THT Biomaterials GmbH

    Vienna, Austria